Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders

Tumor necrosis factor alpha (TNF-?) is an important pro-inflammatory cytokine associated with a variety of ocular diseases. The currently available TNF-? inhibitors are etanercept, infliximab, adalimumab, golimumab, and certolizumab. Experimental and clinical studies on the intravitreal use of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Pascual-Camps, Isabel, Hernández-Martínez, Pablo, Monje-Fernández, Laura, Dolz-Marco, Rosa, Gallego-Pinazo, Roberto, Wu, Lihteh, Arévalo, J Fernando, Díaz-Llopis, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372686/
https://www.ncbi.nlm.nih.gov/pubmed/25825604
http://dx.doi.org/10.1186/s12348-014-0026-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372686/
https://www.ncbi.nlm.nih.gov/pubmed/25825604
http://dx.doi.org/10.1186/s12348-014-0026-8

Ejemplares similares